BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/16/2022 3:57:03 PM | Browse: 251 | Download: 840
Publication Name World Journal of Gastrointestinal Endoscopy
Manuscript ID 72318
Country/Territory Italy
Received
2021-10-11 17:21
Peer-Review Started
2021-10-11 17:23
To Make the First Decision
Return for Revision
2021-12-06 06:05
Revised
2021-12-14 16:30
Second Decision
2022-02-15 03:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-02-16 07:27
Articles in Press
2022-02-16 07:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-02-11 21:31
Typeset the Manuscript
2022-03-10 16:40
Publish the Manuscript Online
2022-03-16 15:57
ISSN 1948-5190 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Observational Study
Article Title SARS-CoV-2 in inflammatory bowel disease population: Antibodies, disease and correlation with therapy
Manuscript Source Invited Manuscript
All Author List Clara Benedetta Conti, Elsa Mainardi, Sara Soro, Sophie Testa, Annalisa De Silvestri, Andrea Drago, Fabrizio Cereatti and Roberto Grassia
ORCID
Author(s) ORCID Number
Clara Benedetta Conti http://orcid.org/0000-0001-9774-2374
Elsa Mainardi http://orcid.org/0000-0003-3522-105X
Sara Soro http://orcid.org/0000-0002-4802-8403
Sophie Testa http://orcid.org/0000-0002-3512-0243
Annalisa De Silvestri http://orcid.org/0000-0003-3128-8441
Andrea Drago http://orcid.org/0000-0002-9777-8665
Fabrizio Cereatti http://orcid.org/0000-0003-0628-4473
Roberto Grassia http://orcid.org/0000-0003-4491-4050
Funding Agency and Grant Number
Corresponding Author Clara Benedetta Conti, MD, Consultant Physician-Scientist, Gastroenterology and Digestive Endoscopy, ASST Cremona, Viale Concordia 1, Cremona 26100, Italy. benedetta.conti1@gmail.com
Key Words Inflammatory bowel disease; SARS-CoV-2; COVID-19; Biologic treatment; SARS-CoV-2 antibody; Inflammatory bowel disease therapy
Core Tip Guidelines recommend ceasing inflammatory bowel disease (IBD) biologic therapy during coronavirus disease 2019 (COVID-19). IBD patients were prospectively tested for severe acute respiratory syndrome coronavirus 2 IgG. In total, 103 IBD patients were enrolled. We found that 18.4% had IgG positivity, and 63% developed COVID-19 disease with symptoms. However, all but one patient with symptoms did not require ceasing IBD treatment no hospitalization. None of the patients under biologic therapy developed severe COVID-19. Therefore, the IBD population does not seem to have a high risk of severe COVID-19, particularly if under biological treatment or mesalazine.
Publish Date 2022-03-16 15:57
Citation Conti CB, Mainardi E, Soro S, Testa S, De Silvestri A, Drago A, Cereatti F, Grassia R. SARS-CoV-2 in inflammatory bowel diseases population: Antibodies, disease and correlation with therapy. World J Gastrointest Endosc 2022; 14(3): 153-162
URL https://www.wjgnet.com/1948-5190/full/v14/i3/153.htm
DOI https://dx.doi.org/10.4253/wjge.v14.i3.153
Full Article (PDF) WJGE-14-153.pdf
Full Article (Word) WJGE-14-153.docx
Manuscript File 72318_Auto_Edited-LLW-Filipodia.docx
Answering Reviewers 72318-Answering reviewers.pdf
Audio Core Tip 72318-Audio core tip.aac
Biostatistics Review Certificate 72318-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 72318-Conflict-of-interest statement.pdf
Copyright License Agreement 72318-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 72318-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 72318-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 72318-Language certificate.pdf
Supplementary Material 72318-Supplementary material.pdf
Peer-review Report 72318-Peer-review(s).pdf
Scientific Misconduct Check 72318-Bing-Wang LL-2.png
Scientific Editor Work List 72318-Scientific editor work list.pdf